Loading...
Loading...
Medtronic, Inc.
MDT today announced that the company has received CE (Conformité Européenne) Mark approval for Medtronic Deep Brain Stimulation (
DBS) Therapy in Europe as adjunctive treatment for partial-onset seizures in adults with medically refractory epilepsy.
DBS therapy for epilepsy delivers controlled electrical pulses to a target in the brain called the anterior nucleus of the thalamus, which is part of a circuit involved in seizures.
Click here to get today's best trading ideas.© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
We simplify the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in